|
|||||
|
|
Magnesium-L-aspartate-HCl and magnesium-oxide: bioavailability in healthy volunteers |
|
| Authors: | B. Mühlbauer M. Schwenk W. M. Coram K. H. Antonin P. Etienne P. R. Bieck F. L. Douglas |
| Affiliation: | (1) Ciba-Geigy GmbH, Human Pharmacology Institute, Tübingen, FRG;(2) Pharmaceuticals Division, Ciba-Geigy Corporation, Summit NJ, USA |
| Abstract: | |
| Keywords: | Magnesium deficiency oral replacement therapy bioavailability adverse effects |
| 本文献已被 SpringerLink 等数据库收录！ | |